Tag: PURENERGY
Americas: ChromaDex initiates second human clinical study for caffeine ingredient, PURENERGY
ChromaDex Corp. has initiated a second human clinical study for PURENERGY, its patented caffeine ingredient.
The Institutional Review Board (IRB)-approved, crossover design study will be...